药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Procarbazine
Fenoterol
Fenoterol may decrease the antihypertensive activities of Ambrisentan.
Procarbazine
Arformoterol
Arformoterol may decrease the antihypertensive activities of Ambrisentan.
Procarbazine
Obinutuzumab
Ambrisentan may increase the hypotensive activities of Obinutuzumab.
Procarbazine
Dexmethylphenidate
Dexmethylphenidate may decrease the antihypertensive activities of Ambrisentan.
Cilostazol
Somapacitan
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Somapacitan.
Cilostazol
Satralizumab
The serum concentration of Saxagliptin can be decreased when it is combined with Satralizumab.
Cilostazol
Abametapir
The serum concentration of Saxagliptin can be increased when it is combined with Abametapir.
Cilostazol
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Saxagliptin.
Cilostazol
Thyroid, porcine
Thyroid, porcine may decrease the hypoglycemic activities of Saxagliptin.
Cilostazol
Tiratricol
Tiratricol may decrease the hypoglycemic activities of Saxagliptin.
Cilostazol
Cenobamate
The serum concentration of Saxagliptin can be decreased when it is combined with Cenobamate.
Cilostazol
Prednisolone acetate
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Saxagliptin.
Cilostazol
Methylprednisolone aceponate
The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Saxagliptin.
Cilostazol
Loteprednol
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Saxagliptin.
Cilostazol
Hydrocortisone succinate
The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Saxagliptin.
Cilostazol
Hydrocortisone valerate
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Saxagliptin.
Cilostazol
Hydrocortisone probutate
The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Saxagliptin.
Cilostazol
Hydrocortisone butyrate
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Saxagliptin.
Cilostazol
Fluclorolone
The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Saxagliptin.
Cilostazol
Formocortal
The risk or severity of hyperglycemia can be increased when Formocortal is combined with Saxagliptin.